Low dose rate versus high dose rate intraluminal brachytherapy for malignant endobronchial tumors

Lo, Theodore C.M.; Girshovich, Lyubov; Healey, Glenn A.; Beamis, John F.; Webb-Johnson, David C.; Villanueva, Andrew G.; Gray, Anthony W.; Wu, Terence

doi:10.1016/0958-3947(95)01557-8

Cited by 6 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the present time, there is no evidence that one dose rate is superior to another in terms of improved local control or decreased morbidity [3,33]. The American Brachy- Greater degree of fibrosis with resulting circumferential stenosis leading to a decrease in lumenal diameter.…”

Section: Discussionmentioning

confidence: 96%

See 1 more Smart Citation

Brachytherapy in lung cancer

Gaspar

1998

J. Surg. Oncol.

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 96%

“…Brachytherapy is an accepted treatment for recurrent symptomatic endobronchial disease [3,19,26,27,[33][34][35]. Tables II and III summarize selected reports utilizing LDR or HDR brachytherapy at the time of recurrence.…”

Section: Palliative Brachytherapy: Recurrences Following External Beamentioning

confidence: 98%

Brachytherapy in lung cancer

Gaspar

1998

J. Surg. Oncol.

View full text Add to dashboard Cite

“…Giving fractionated doses of 500-700 cGy through bronchoscopes improves symptoms of dyspnoea, haemoptysis and postobstructive pneumonia with response rates of 66-95%. [9][10][11][12] Though there has been anecdotal evidence suggesting that hormone manipulation may reduce prostatic bleeding in cancer, there is no published data to support this. Foley et al…”

Section: Discussionmentioning

confidence: 99%

Brachytherapy for advanced prostate cancer bleeding

Thurairaja

Pocock

Crundwell

et al. 2008

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

Advanced prostate cancer patients frequently deal with intractable prostatic bleeding which is a difficult problem to manage. Intraurethral high-dose rate (HDR) brachytherapy may palliate this condition. Advanced prostate cancer patients with intractable prostatic bleeding were offered brachytherapy with Iridium-192 using a Micro-selectron HDR machine. During a 5-year period, analysis was performed in 23 patients with a median age and Gleason score of 78 years and 9, respectively. Following brachytherapy, haematuria resolved in 19 of the 23 patients and was recurrence free at 6 months. Intraurethral HDR brachytherapy is a potentially effective modality for treating haematuria in patients with advanced prostate cancer.

show abstract

“…Lo et al compared the two rates and found similar clinical and bronchoscopic improvements. 35 Speiser and Spratling compared IDR with HDR and also found both to be equally effective. 29 The economic advantage of HDR technology is based on outpatient therapy.…”

Section: Hdr Versus Ldrmentioning

confidence: 97%